http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100481188-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate | 1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100481188-B1 |
| titleOfInvention | Use of Alkanoyl-L-Carnitine for the Treatment of Glutamate-Related Diseases |
| abstract | The present invention relates to the use of alkanoyl L-carnitine such as acetyl L-carnitine or a pharmaceutically usable salt thereof for providing a medicament capable of treating or preventing glutamate related cytological disorders or diseases. |
| priorityDate | 1996-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.